EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of life

Login S George, Paul R Duberstein iD, Nancy L Keating, Benjamin Bates, Divya Bhagianadh, Haiqun Lin, Biren Saraiya, Sanjay Goel iD, Ayse Akincigil

Cancer · 2024

DOI: 10.1002/cncr.35488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancer, 2024. Verfasst von Login S George und 8 weiteren Autor:innen. Beteiligte Einrichtung: Rutgers University, New Brunswick, New Jersey, USA. Hauptthemen laut MEDLINE: Terminal Care, Oncologists, Practice Patterns, Physicians', Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 51 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, Rutgers Cancer Institute of New Jersey, National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Clinical guidelines and quality improvement initiatives have identified reducing the use of end‐of‐life cancer therapies as an opportunity to improve care. We examined the extent to which oncologists differed in prescribing systemic therapies in the last 30 days of life.

Methods

Using Surveillance, Epidemiology, and End Results–Medicare data, we identified patients who died of cancer from 2012 to 2017 ( N = 17,609), their treating oncologists ( N = 960), and the corresponding physician practice ( N = 388). We used multilevel models to estimate oncologists’ rates of providing cancer therapy for patients in their last 30 days of life, adjusted for patient characteristics and practice variation.

Results

Patients’ median age at the time of death was 74 years (interquartile range, 69–79); patients had lung (62%), colorectal (17%), breast (13%), and prostate (8%) cancers. We observed substantial variation across oncologists in their adjusted rate of treating patients in the last 30 days of life: oncologists in the 95th percentile exhibited a 45% adjusted rate of treatment, versus 17% among the 5th percentile. A patient treated by an oncologist with a high end‐of‐life prescribing behavior (top quartile), compared to an oncologist with a low prescribing behavior (bottom quartile), had more than four times greater odds of receiving end‐of‐life cancer therapy (OR, 4.42; 95% CI, 4.00–4.89).

Conclusions

Oncologists show substantial variation in end‐of‐life prescribing behavior. Future research should examine why some oncologists more often continue systemic therapy at the end of life than others, the consequences of this for patient and care outcomes, and whether interventions shaping oncologist decision‐making can reduce overuse of end‐of‐life cancer therapies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Terminal CareOncologistsPractice Patterns, Physicians'NeoplasmsSEER ProgramHumansAgedMaleFemaleAged, 80 and overUnited StatesMedicareMedical Oncology

Stichwörter der Autor:innen

care intensitydecision makingend‐of‐life carelow‐value carephysician behaviorphysician variationpractice variation

Autor:innen und Institutionen

  • Rutgers University, New Brunswick, New Jersey, USA.
  • Harvard Medical School, Boston, Massachusetts, USA.

ORCID-Profile: Paul R Duberstein, Sanjay Goel

Förderung

  • NCI NIH HHS
  • Rutgers Cancer Institute of New Jersey
  • National Cancer Institute

Zitieren

APA

George, L. S., Duberstein, P. R., Keating, N. L., Bates, B., Bhagianadh, D., Lin, H., Saraiya, B., Goel, S., & Akincigil, A. (2024). Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of life. Cancer. https://doi.org/10.1002/cncr.35488

Vancouver

George LS, Duberstein PR, Keating NL, Bates B, Bhagianadh D, Lin H, et al. Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of life. Cancer. 2024. doi:10.1002/cncr.35488

BibTeX
@article{George2024,
  author = {George, Login S and Duberstein, Paul R and Keating, Nancy L and Bates, Benjamin and Bhagianadh, Divya and Lin, Haiqun and Saraiya, Biren and Goel, Sanjay and Akincigil, Ayse},
  title = {Estimating oncologist variability in prescribing systemic cancer therapies to patients in the last 30 days of life},
  journal = {Cancer},
  year = {2024},
  doi = {10.1002/cncr.35488}
}
Kostenlos starten →